Venetoclax-Azacitidine Salvage Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Single-Center Experience

Authors

DOI:

https://doi.org/10.14740/jh1362

Abstract

N/A

Downloads

Published

2025-04-26

Issue

Vol. 14, No. 2, Apr 2025

Section

Letter to the Editor

License

Copyright (c) 2024 Journal of Hematology

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

1.
Osman D, Maroto ML, Kinsella F, Murthy V. Venetoclax-Azacitidine Salvage Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Single-Center Experience. J Hematol. 2025;14(2):105-108. doi:10.14740/jh1362